2020年8月31日

衣服可以殺死99.9%病毒!多倫多公司成功研發抗病毒布料 | Canadian biotech company says its anti-viral clothing kills 99.9 per cent of coronavirus

衣服可以殺死99.9%病毒!多倫多公司成功研發抗病毒布料

多倫多1間生物科技公司,就預防新型冠狀病毒方面,研發出領先新方法──防病毒布料。

總部位於多倫多的Intelligent Fabric Technologies(簡稱IFTNA),行政總裁Giancarlo Beevis表示,在大約10年前,已認識到需要有抗病毒的布料;他表示:「若果有人將餐巾折疊成天鵝,但其手上沾染了病毒,客人再將餐巾抹口,便會感染病毒,而且病毒不斷被傳播」。

IFTNA表示,過去一直試圖開發1種處理紡織品的技術,但直至新冠病毒爆發時才研發成功。

該公司表示,將推出1種名為PROTX2 AV的抗病毒化學品,塗在布料上,可將病毒殺死。

IFTNA的上市母公司iFabric Corp(IFA),已於5月時宣布,在獨立實驗室中的測試結果證實,使用PROTX2技術處理過的布料,有99.9%「活性病毒量」減少。

Beevis表示,不論經10分鐘、1小時、6小時或24小時測試,帶有PROTX2技術的布料,即使在最短時間內,亦顯示出有99.9%病毒被殺死。

該化學品是將病毒周圍的脂肪染色體,於數分鐘內被破壞。

但該公司表示,帶有PROTX2技術的布料,經洗滌30次後,PROTX2溶液會從衣服上磨損。

該公司已經跟Under Armour合作,推出專門針對運動員使用,經PROTX2技術處理的口罩。


新聞來源:星島

相關文章:
Under Armour發表新的3D列印運動鞋技術 | SHOEMAKING RECONSIDERED: UNDER ARMOUR REVEALS 3D-PRINTED SNEAKERS
Under Armour攜手維珍銀河 開發太空衣 | Under Armour Is Blasting Off Into a New Market: Spacesuits
復仇者盔甲下的祕密,Under Armour 特製高科技機能緊身衣
臺美產業合作成功案例:美國運動服飾品牌的最佳夥伴在臺灣



Canadian biotech company says its anti-viral clothing kills 99.9 per cent of coronavirus

A Toronto-based biotech company is a frontrunner in developing a new kind of COVID-19 protection: antiviral clothing, made to protect against the virus.

We have sanitizer for our hands, wipes for counters and masks for our faces. Is anti-viral clothing the next stage?

Intelligent Fabric Technologies (North America) Inc. (IFTNA) is trying to get a stitch up on the competition.

CEO Giancarlo Beevis first saw the need for anti-viral fabric 10 years ago, when there was an outbreak of norovirus on cruise ships.

“If the person folding the napkin into a swan -- or whatever it was supposed to look like -- on your buffet table had norovirus on [their] hands, it was transmitting when you went to wipe your mouth,” he told NewsNight by CTV News, available on the streaming app Quibi.

“There was nothing active in between use that was protecting it from getting the virus on the napkin.”

IFTNA developed a technology to treat textiles, but it wasn’t until this pandemic that the idea caught fire.

“So as this hit, we said, well, why not? We think it [will] work. Let's give it a try and let's find someone who can test COVID-19,” he said.

They came out with an anti-viral chemical called PROTX2 AV -- a fabric coating that aims to kill the virus on contact.

iFabric Corp, the parent company for IFTNA, announced on May 11 that test results in an independent laboratory had shown that fabric treated with PROTX2 AV technology showed a 99.9-per-cent reduction in “active viral loads.”

“This represents a more than 1,000-fold reduction in active viral load when compared to untreated fabric,” the press release stated.

Beevis said they tested fabrics with PROTX2 AV on it at 10 minutes, one hour, six hours and 24 hours -- and showed the same 99.9 per cent kill rate even in the smallest time frame.

So how does it work?

The chemical targets the fatty molecules that surround viruses, destroying them in minutes. The idea is that if your clothing comes into contact with COVID-19, it acts as a shield.

After 30 washes, the PROTX2 AV solution becomes less efficient.

It has also been tested against other pathogens, including norovirus, H1N1 and e.coli, according to the company’s website. It is currently recognized by the U.S. Environmental Protection Agency (EPA), according to the website. In the May press release, the company said it had an emergency approval in progress at Health Canada.

But this is just the beginning, Beevis says.

“You're talking about everyday loungewear and athleisure wear,” he said, adding that it could morph into “a travel line.”

The company has already collaborated with Under Armour to release a face mask treated with PROTX2 AV, specifically designed for athletes.

And this kind of technology brings potential applications for the frontline.

Dr. Amber Mitchell, an infectious disease expert, said that “it’s really difficult to disinfect a textile versus, let’s say, a stainless steel surface that you may see in health care.

“Because of all of the nooks and crannies that are on the clothing itself […] There's a lot of dips and valleys where the viral particles like to live.”

And lab coats are one of the biggest germ carriers.

A fresh set of scrubs is worn every day, but “lab coats tend to stick around in the facility,” Mitchell said.

“They'll go on the back of a door hanger. And then that lab coat is [worn] over and over and over again. especially during a pandemic, because they're so infrequently washed that, especially at the pocket level, […] these can really be potential harbors for a large amount of microbial or viral growth.”

Although surface transmission isn’t thought to be a major source of transmission for COVID-19, anti-viral clothing could also bring peace of mind to wearers.

Analysts expect the global surgical apparel market to reach about 19 billion dollars by 2025, and the antimicrobial textiles market to surpass 20.5 billion by 2026.

The luxury market is also banking on this innovation. Albini Group supplies dress shirt fabrics to Harry Rosen, Armani and Prada, and has developed their own anti-viral fabric treatment, called Viroformula.


Original Article: CTV News

2020年8月4日

臺灣防疫戰略供應鏈,聚陽防護衣2.0年底投產



臺灣防疫戰略供應鏈,聚陽防護衣2.0年底投產 17年前的防護衣專利壓箱寶,是成衣廠聚陽躋身國家隊關鍵,即使後來遭到政府砍單,董事長周理平說,推動P3防護衣2.0決心不變,因為疫情有可能再次襲來,建立本土防疫戰略供應鏈的事,「不能停下來」。

2月時,當武漢肺炎疫情肆虐,成衣廠集結起來組成紡織防疫國家隊,協助政府生產防護衣/隔離衣,當時,聚陽頂著全台首家生產P3防護衣的光環,名聲大噪。 

周理平不諱言地說,畢竟是第一次生產高等級防護衣,有時候在熱壓邊條時布料起皺,一旦有皺痕,就有產生孔隙的疑慮,生產線上會打掉視為失敗品,以至於良率持續偏低。 

為了提升良率,聚陽持續研發,2.0品質更加穩定,目前正準備申請GMP、ISO認證,以及美國FDA、歐盟CE等醫材認證,預計今年9月、10月後正式量產。 

周理平表示,屆時2.0版仍是在嘉義廠生產,規劃月產能約5萬件。 

不過問起,先前被政府調節防護衣訂單,為何還要持續研發? 

他說,目前國外疫情持續升溫,即使臺灣防疫成功,也不能掉以輕心,為避免疫情再次襲來或是其他不明病毒大規模傳染,防疫物資仍是不可缺乏,因此建立本土防疫戰略供應鏈是他的想法,也持續執行中。 

有趣的是,周理平說,一旦2.0確定可以投產,屆時還是會跟衛福部與經濟部提案,後續也規劃在柬埔寨增設產線,鎖定海外市場拓銷。 


新聞來源: 中央通訊社